Artikel
Correlation of 5-ALA derived porphyrins to contrast enhancement in MRI, Amino acid-PET, IDH1 mutation, 1p19q deletion and MGMT promoter methylation in gliomas
Suche in Medline nach
Autoren
Veröffentlicht: | 13. Mai 2014 |
---|
Gliederung
Text
Objective: The aim of this study was to assess histological and imaging factors associated with the intraoperative accumulation of 5-aminolaevulinic acid (5-ALA) derived porphyrins in gliomas.
Method: Retrospectively, we analyzed the data of patients operated at our department between 01/2012 and 05/2013 regarding 5-ALA induced porphyrins during resection, enhancement on pre-operative MRI, and O-(2-(18)F-fluoroethyl)-l-tyrosine ((18)F-FET) PET or 11-C-Methionine (MET) PET hypermetabolism. Further, intraoperative fluorescence findings were related to IDH1 mutation and MGMT promoter methylation, as examined by direct sequencing and methylation-specific PCR, respectively, and 1p19q co-deletion as detected by fluorescence in situ hybridization. We studied 257 gliomas (153 glioblastomas and 4 gliosarcomas, 45 anaplastic astrocytomas, 16 anaplastic oligodendrogliomas or anaplastic oligoastrocytomas, 34 astrocytomas and 5 oligodendrogliomas). 255 of 257 patients were operated by fluorescence guided surgery and 253 contrast MRIs were performed. 196 MGMT promoter methylation status were recorded, 155 IDH1 mutations and 21 1p19q deletions were analyzed.
Results: ALA-induced fluorescence correlated with contrast enhancement (P<0.001), ALA MGMT promoter methylation (P<0.001) and IDH1 mutation status (P<0.001). No significant correlation was found between fluorescence and hypermetabolism in the amino acid PET (P=0.160) or 1p19q deletion (P=0.081).
Conclusions: Our results help predict ex ante whether ALA application could be of use in individual patients. They also indicated that molecular factors may be involved in determining porphyrin accumulation in gliomas.